Respiratory muscle function in pulmonary hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00003567

Enrollment

Registered

2012-02-27

Start date

2007-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I27.0

Interventions

Group 1: Prior and post 3 week rehabilitation the following measurements will be performed: Tests of respiratory muscle strength Lung function Blood gas analysis Six minute walking test with assessmen

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Established diagnosis of pulmonary hypertension (Dana Point class I) (NYHA class III-IV) and treatment in an established center according to current recommendations.

Exclusion criteria

Exclusion criteria: Other forms of pulmonary hypertension that are not covered in Dana Point class I rib cage abnormalities neuromuscular disorders systemic steroid therapy diabetes cachexia

Design outcomes

Primary

Measure	Time frame
Evaluation of respiratory muscle strength at the beginning and after three weeks of stationary rehabilitation.	—

Secondary

Measure	Time frame
Secondary endpoints following rehabilitation are: Increase in lung function parameters Inrease in blood gas parameters (oxygenation) Increase in walking distance Improvement of dyspnea ratings.	—

Countries

Germany

Contacts

Public ContactHans-Joachim Kabitz

Uniklinik Freiburg Abt. Pneumologie

hans-joachim.kabitz@uniklinik-freiburg.de004076127074070

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026